9:00am - 5:00pm

Our Opening Hours Mon. - Fri.

1.800.799.2234

Call Us For Free Consultation

Facebook

Twitter

Search
 

Ganetespib With Platinum, in Patients With Malignant Pleural Mesothelioma

Top West Virginia Mesothelioma Lawyer | Law Firm | Attorney | GPW > Ganetespib With Platinum, in Patients With Malignant Pleural Mesothelioma

Ganetespib With Platinum, in Patients With Malignant Pleural Mesothelioma

Estimated reading time: < 1 min

Condition: Lung Cancer – Malignant Pleural Mesothelioma

Estimated Enrollment: 27

Gender: All

Min Age: 18 Years

Age Group: Adult, Older Adult

Current Status: Active, not recruiting

Study Results: No Results Available

Outcome Measures: Maximum Tolerated Dose of Ganetespib,  Progression Free Survival,  ,

Interventions: Ganetespib,

Phase:

Study Type: Interventional

Study Design: Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: None (Open Label),Primary Purpose: Treatment

Primary Completion Date: October 2019

Completion Date: November 2019

Last  Posted Date: January 31, 2019

Location: UCL Cancer Trials Centre, London, United Kingdom

Website Link: https://ClinicalTrials.gov/show/NCT01590160

Was this article helpful?
Dislike 0